Trial Profile
Evaluation of risk factors for intra-abdominal abscess in Crohn's disease patients treated with infliximab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- 02 Dec 2015 New trial record